Evaluation of possible transplacental infection with rubella vaccination during pregnancy.
D000028:Abortion, Induced; D000328:Adult; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D000917:Antibody Formation; D002584:Cervix Uteri / Q000382:microbiology; D004622:Embryo, Mammalian / Q000382:microbiology; D005069:Evaluation Studies as Topic; D005260:Female; D005315:Fetal Diseases / Q000209:etiology*; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D011817:Rabbits; D012409:Rubella / Q000209:etiology / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000009:adverse effects*; D012412:Rubella virus / Q000302:isolation & purification; D014611:Vaccination / Q000009:adverse effects; D014613:Vaccines, Attenuated / Q000009:adverse effects*; D014776:Virus Cultivation
D000914:Antibodies, Viral; D012411:Rubella Vaccine; D014613:Vaccines, Attenuated